Q2 2021

Source filing unavailable

Q2 2021 · —

Revenue

€4.32B

−5.2% vs Q2 2020

Net Income

€218.58M

−37.7% vs Q2 2020

EPS Diluted

€0.75

−37.5% vs Q2 2020

Gross Profit€1,283,993,000−10.6%

Operating Income€424,221,000−35.3%

Operating Cash Flowderived

Same quarter

Metric	Q2 2021	Q2 2020	Q2 2019	Q2 2018
Revenue	€4.32B	€4.56B	€4.35B	€4.21B
Net Income	€218.58M	€350.97M	€253.78M	€993.98M
EPS Diluted	€0.75	€1.20	€0.84	€3.23

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Fresenius Medical Care AG · CIK 1333141 · Engraved from SEC EDGAR